A pilot study of manual chronic partial exchange transfusion in children with sickle disease

References

• Gulbis B, Cotton F, Ferster A, Ketelslegers O, Dresse MF, Rongé-Collard E, et al. Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol. 2009;62:49–52.
   PubMed Web of Science ®Google Scholar
• Gulbis B, Ferster A, Cotton F, Lebouchard MP, Cochaux P, Vertongen F. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels. J Med Screen. 2006;13:76–8.
   PubMed Web of Science ®Google Scholar
• Gulbis B, Ferster A, Vermylen C, Dresse MF, Vanderfaeillie A, Delannoy A, et al. Red Blood Cell Disorders Subcommittee of the Belgian Haematological Society. An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry). Hemoglobin 2008;32:279–85.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–44.
   PubMed Web of Science ®Google Scholar
• Eckman JR. Techniques for blood administration in sickle cell patients. Semin Hematol. 2001;38:30–6.
   PubMed Web of Science ®Google Scholar
• Danielson CF. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher. 2002;6:24–31.
   PubMedGoogle Scholar
• Swerdlow PS. Red cell exchange in sickle cell disease. Hematol Am Soc Hematol Educ Program. 2006:48–53.
   PubMedGoogle Scholar
• Lanzskowski P, Shende A, Karayalcin G, Kim YJ, Aballi AJ. Partial exchange transfusion in sickle cell anemia. Am J Dis Child. 1978;132:1206.
   PubMedGoogle Scholar
• Porter JB, Huehns ER. Transfusion and exchange transfusion in sickle cell anemias, with particular reference to iron metabolism. Acta Haematol. 1987;78:198.
   PubMed Web of Science ®Google Scholar
• Aygun B, McMurray MA, Schultz WH, Kwiatkowski JL, Hilliard L, Alvarez O, et al. SWITCH Trial Investigators. Chronic transfusion practice for children with sickle cell anaemia and stroke. Br J Haematol. 2009;145:524–8.
   PubMed Web of Science ®Google Scholar
• Klein HG, Garner RJ, Miller DM, Rosen SL, Statham NJ, Winslow RM. Automated partial exchange transfusion in sickle cell anemia. Transfusion 1980;20:578–84.
   PubMed Web of Science ®Google Scholar
• Payne KA, Rofail D, Baladi JF, Viala M, Abetz L, Desrosiers MP, et al. Iron chelation therapy: clinical effectiveness, economic burden and quality of life in patients with iron overload. Adv Ther. 2008;25:725–42.
   PubMed Web of Science ®Google Scholar
• Savage WJ, Reddoch S, Wolfe J, Casella JF. Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease. J Pediatr Hematol Oncol. 2013;35:434–6.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski JL, Cohen AR, Garro J, Alvarez O, Nagasubramanian R, Sarnaik S, et al. SWiTCH Study Investigators. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention. Am J Hematol. 2012;87:221–3.
   PubMed Web of Science ®Google Scholar
• Cohen A. Management of iron overload in the pediatric patient. Hematol Oncol Clin North Am. 1987;1:521–44.
   PubMedGoogle Scholar
• Files B, Brambilla D, Kutlar A, Miller S, Vichinsky E, Wang W, et al. Longitudinal changes in ferritin during chronic transfusion: a report from the stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol. 2002;24:284–90.
   PubMed Web of Science ®Google Scholar
• Fung EB, Harmatz P, Milet M, Balasa V, Ballas SK, Casella JF, et al. Multi-center iron overload research group. Am J Hematol. 2007;82:255–65.
   PubMed Web of Science ®Google Scholar
• Cohen AR, Buchanan GR, Martin M, Ohene-Frempong K. Increased blood requirements during long-term transfusion therapy for sickle cell disease. J Pediatr. 1991;118:405.
   PubMed Web of Science ®Google Scholar
• Porter JB, Huehns ER. Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism. Acta Haematol. 1987;78:198.
   PubMed Web of Science ®Google Scholar
• Adamkiewicz TV, Abboud MR, Paley C, Olivieri N, Kirby-Allen M, Vichinsky E, et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood 2009;114:4632–8.
   PubMed Web of Science ®Google Scholar
• Tsitsikas DA, Nzouakou R, Ameen V, Sirigireddy B, Amos RJ. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease. Eur J Haematol. 2014;92:164–7.
   PubMed Web of Science ®Google Scholar
• Cabibbo S, Fidone C, Garozzo G, Antolino A, Manenti GO, Bennardello F, et al. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease. Transf Apher Sci. 2005;32:315–21.
   PubMed Web of Science ®Google Scholar
• Riddington C, Wang W. Blood transfusion for preventing stroke in people with sickle cell disease. Cochrane Database Syst Rev. 2002;(1):CD003146.
   PubMedGoogle Scholar
• Liem RI, O'Gorman MR, Brown DL. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome. Am J Hematol. 2004;76:19–25.
   PubMed Web of Science ®Google Scholar
• O'Callaghan A, O'Brien SG, Ninkovic M, Butcher GP, Foster CS, Walters JR, et al. Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion. Gut. 1995;37:144–7.
   PubMed Web of Science ®Google Scholar
• Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, et al. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events. The Belgian experience. Blood 2005;105:2685–90.
   PubMed Web of Science ®Google Scholar